By Eileen Soreng
(Reuters) – Gold prices edged up on Thursday, after dropping over 1% in the previous session, as concerns over the economic fallout from surging COVID-19 cases outweighed positive development around a vaccine.
Spot gold rose 0.2% to $1,868.81 per ounce by 0549 GMT, while U.S. gold futures were 0.3% higher at $1,866.30 per ounce.
Gold is down 4.2% this week after Monday’s encouraging late-stage coronavirus vaccine trial data from Pfizer Inc <PFE.N> and BioNTech <BNTX.O>."Gold traders are trying to strike a balance between a positive vaccine news and a rising number of coronavirus cases around the globe," said Margaret Yang, a strategist with DailyFx, which covers currency, commodity and index trading.Although the vaccine may affect the medium-to-long-term trends of gold prices, monetary and fiscal stimulus are needed in the near-term to shelter the global economy, Yang said.European Central Bank President Christine Lagarde signalled further support for the economy on […]
- Do contribute something to the discussion
- Do post factual information, analysis and your view on company valuations
- Do disclose if you have an interest in a security
- Do not make low-content posts, unsubstantiated ramps or untruthful/misleading statements
- Do not complain about a post unless you have reported it first, and not on the forum.
- Do not post financial advice
- Do not advertise or post sponsored content